8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The Cumulative Effects of the MYH7 -V878A and CACNA1C -A1594V Mutations in a Chinese Family with Hypertrophic Cardiomyopathy

      case-report

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims: We investigated the pathogenesis of MYH7-V878A and CACNA1C-A1594V mutations in a Chinese family with hypertrophic cardiomyopathy. Methods: Clinical, electrocardiographic (ECG), echocardiographic, and cardiac magnetic resonance (CMR) examinations of members of a Chinese family were followed by exon and boarding intron analyses of 96 genes in the proband using second-generation sequencing. We confirmed the mutations by bidirectional Sanger sequencing in the members and in 300 healthy controls. Results: We detected MYH7-V878A and CACNA1C-A1594V mutations in this family. The members with both mutations showed inverted T-waves and ST-segment depression in ECG recordings, severe left ventricular (LV) hypertrophy in echocardiography, and myocardial fibrosis in CMR; subject II-11 did not show late gadolinium enhancement. Among those with only the MYH7-V878A mutation, subject III-7 showed abnormal ECG recordings, asymmetric septal hypertrophy, and myocardial fibrosis, and subjects II-13 and III-15 showed some abnormal repolarization, borderline LV wall thickness, and normal CMR findings. Those with only the CACNA1C-A1594V mutation showed nearly normal readings in all examinations. The members with both mutations displayed more severe LV hypertrophy and elevated LV filling pressure than those with 1 or no mutation ( p < 0.05). Conclusion: Our results suggest that the pathogenesis of MYH7-V878A and CACNA1C-A1594V mutations may have a cumulative effect.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          2017
          December 2017
          02 September 2017
          : 138
          : 4
          : 228-237
          Affiliations
          Departments of aUltrasound, bRadiology and cCardiology, Xijing Hospital, Fourth Military Medical University, dUltrasound, Xi'an Children's Hospital of Xi'an Jiaotong University, eChildren's Research Institute of Shaanxi Province, and fDepartment of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China
          Author notes
          *Prof. Li-Wen Liu, Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, 127# Changle West Road, Xi'an, Shaanxi 710032 (China), E-Mail liuliwen@fmmu.edu.cn, Prof. Yan-Min Zhang, Department of Ultrasound, Xi'an Children's Hospital of Xi'an Jiaotong University, Children's Research Institute of Shaanxi Province, 127# Changle West Road, Xi'an, Shaanxi 710032 (China), E-Mail ymzh@126.com, Li-Feng Wang, PhD, Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, 127# Changle West Road, Xi'an, Shaanxi 710032 (China), E-Mail lfwang@fmmu.edu.cn
          Article
          478900 Cardiology 2017;138:228-237
          10.1159/000478900
          28866666
          1d64020b-cfb0-4149-b9a1-ca11f4542c4a
          © 2017 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 16 February 2017
          : 21 June 2017
          Page count
          Figures: 4, Tables: 3, References: 26, Pages: 10
          Categories
          Original Research

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Hypertrophic cardiomyopathy,Cumulative effect, MYH7-V878A mutation, CACNA1C-1594V mutation

          Comments

          Comment on this article